{
    "organizations": [],
    "uuid": "e79cf9b5301be504eee2324729d7aaa4b60b1275",
    "author": "",
    "url": "https://www.reuters.com/article/brief-catalyst-pharmaceuticals-announces/brief-catalyst-pharmaceuticals-announces-plans-to-resubmit-new-drug-application-for-firdapse-idUSFWN1Q20U8",
    "ord_in_thread": 0,
    "title": "BRIEF-Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 11 PM / Updated 11 minutes ago BRIEF-Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse Reuters Staff \nFeb 12 (Reuters) - Catalyst Pharmaceuticals Inc: \n* CATALYST PHARMACEUTICALS ANNOUNCES PLANS TO RESUBMIT NEW DRUG APPLICATION FOR FIRDAPSEÂ® \n* CATALYST PHARMACEUTICALS - CURRENTLY ANTICIPATES RESUBMITTING NDA FOR FIRDAPSE FOR LEMS TO FDA BY END OF Q1 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-02-12T15:11:00.000+02:00",
    "crawled": "2018-02-12T15:36:08.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "announces",
        "plan",
        "resubmit",
        "new",
        "drug",
        "application",
        "firdapse",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "catalyst",
        "pharmaceutical",
        "inc",
        "catalyst",
        "pharmaceutical",
        "announces",
        "plan",
        "resubmit",
        "new",
        "drug",
        "application",
        "catalyst",
        "pharmaceutical",
        "currently",
        "anticipates",
        "resubmitting",
        "nda",
        "firdapse",
        "lem",
        "fda",
        "end",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}